Testing effectiveness (Phase 2)Study completedNCT03770273
What this trial is testing
Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis
Who this might be right for
Indolent Systemic Mastocytosis
National Institute of Allergy and Infectious Diseases (NIAID) 21